indolmycin   Click here for help

GtoPdb Ligand ID: 11021

Synonyms: PA 155 A | PA-155-A | PA-155A | TAK-083
PDB Ligand Antimalarial Ligand
Compound class: Synthetic organic
Comment: Indolmycin competitively inhibits bacterial tryptophanyl-tRNA synthetases. It has antibacterial activity against MSSA (methicillin-susceptible Staphylococcus aureus), MRSA (methicillin-resistant S. aureus) and VISA (vancomycin-intermediate S. aureus) [2]. The compound also has antimalarial activity [3].

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 2
Topological polar surface area 66.48
Molecular weight 257.12
XLogP 1.96
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN=C1NC(=O)[C@@H](O1)[C@@H](c1c[nH]c2c1cccc2)C
Isomeric SMILES CN=C1NC(=O)[C@@H](O1)[C@@H](c1c[nH]c2c1cccc2)C
InChI InChI=1S/C14H15N3O2/c1-8(12-13(18)17-14(15-2)19-12)10-7-16-11-6-4-3-5-9(10)11/h3-8,12,16H,1-2H3,(H,15,17,18)/t8-,12+/m1/s1
InChI Key GNTVWGDQPXCYBV-PELKAZGASA-N
Guide to Malaria Pharmacology Comments
Indolmycin, like a number of other antibacterials, kills the malaria parasite in the lifecycle after treatment starts.

Target Candidate Profile (TCP): the proposed molecular target is Plasmodium apicoplast tryptophanyl-tRNA synthetase (PfaWRS).